USB Pharma (UCB farma)
Russia
Central Federal District of the Russian Federation
Moscow
Shabolovka st. 10 building 2, floor 3
UCB specializes in the development of four therapeutic directions: central nervous system, respiratory diseases and allergies, inflammatory processes and immunology Oncology
UCB is headquartered in Brussels, Belgium.
The mission of the biopharmaceutical company UCB is to treat serious diseases with the latest therapeutic solutions. UCB combines world-class infrastructure, many years of experience in the pharmaceutical industry, high rates of development and innovation.
UCB has three research centres in the cities of Slough and Cambridge (UK), as well as Broken L'Allou (Belgium). In 2005, the company invested 511 million euros in a research and development program.
UCB is more than 8,500 employees in 40 countries, including 1,700 scientists working in research organizations around the world.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |